The correlation between recurrent risk and CYP2C19 gene polymorphisms in patients with ischemic stroke treated with clopidogrel for prevention

BACKGROUND: To explore the correlation between recurrent risk and CYP2C19 gene polymorphisms in patients with ischemic stroke (IS) treated with clopidogrel for prevention. METHODS: A total of 289 patients with IS treated with clopidogrel regularly were enrolled in this study, and stroke recurrence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Guohua, Yang, Sufang, Chen, Siqia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440096/
https://www.ncbi.nlm.nih.gov/pubmed/32176040
http://dx.doi.org/10.1097/MD.0000000000019143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440096/
https://www.ncbi.nlm.nih.gov/pubmed/32176040
http://dx.doi.org/10.1097/MD.0000000000019143

Ejemplares similares